Betti Ordasi

Novel continuous flow technology for the development of a nanostructured aprepitant formulation with improved pharmacokinetic properties.

T. Solymosi, F. Darvas, G. Filipcsei, 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Dose Escalation Study to Assess the Pharmacokinetic Parameters of a Nano-amorphous Oral Sirolimus Formulation in Healthy Volunteers

L. Molnár, T. Solymosi, J. McDermott, 2019, European Journal of Drug Metabolism and Pharmacokinetics.

Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements.

L. Molnár, T. Solymosi, G. Filipcsei, 2017, International journal of pharmaceutics.

Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect

L. Molnár, T. Solymosi, G. Filipcsei, 2017, Cancer Chemotherapy and Pharmacology.

Novel continuous flow technology for the development of a nanostructured aprepitant formulation with improved pharmacokinetic properties.

T. Solymosi, F. Darvas, G. Filipcsei, 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.